Monograph Capital Advisors, L.P.
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://monograph.bio/
- HQ
- CA
Monograph Capital Advisors invests in innovative life sciences companies, aiming to translate promising science into life-changing treatments for patients. Its team includes partners and principals based in San Francisco and London. Portfolio companies include Ascend, a gene-to-GMP manufacturer, Autobahn, which is developing an adjunctive depression therapy, Nocion Therapeutics, and Prolynx, which focuses on ultra-long-acting obesity medicines. The firm also backs RegASK, a regulatory technology company.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Digital health, Biotech | Not enough dated deals |
| Regions | Global | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Monograph Capital Partners II, L.P. Monograph Capital finds and funds innovative life sciences companies, aiming to translate promising science into potential life-changing treatments for patients. The team focuses on sourcing scientific innovation and supporting strong companies, combining sourcing, pharma relationships and medical expertise. Inferred from the firm's website | 2024 | $153.69M (Form D) | Open, writing first checks |
03 · People across funds
- Charles Conn, Partner, MBA, MA
Monograph Capital Partners II, L.P. (Named on Form D)
- Fred Cohen, Partner and Chairman, MD, DPhil
Monograph Capital Partners II, L.P. (Named on Form D)
- Charlie Zhou, Advisor (in Portfolio), MPH, BM BCh, MA
- Freddie Dear, Principal (Portfolio), BSc
- Jaideep Dudani, Principal (Portfolio), PhD, BS
- Jennifer Shah, Head of Capital Formation, BA
- Jeremias Reich, Associate, MBBS, BSc
- Matt McAviney, Partner, MBA, MD
- Melisa Guven, Principal, PhD, MSc, BSc
- Michelle He, Associate, BSc
- Mike LaGatta, Partner and COO, JD, MBA, LLM
- Oscar Molina, Associate, PhD, BS
- Tim Funnell, Partner, DPhil, BS
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://monograph.bio/
- https://www.monograph.bio/contact
- https://www.monograph.bio/portfolio
- https://www.monograph.bio/
- https://www.monograph.bio/team
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026